Hims & Hers Health (HIMS) Competitors

Hims & Hers Health (NYSE:HIMS) and Teladoc Health (NYSE:TDOC) are both mid-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, community ranking, profitability, valuation and dividends.

Do analysts recommend HIMS or TDOC?

Hims & Hers Health presently has a consensus target price of $14.85, suggesting a potential upside of 20.31%. Teladoc Health has a consensus target price of $22.23, suggesting a potential upside of 68.67%. Given Teladoc Health's higher possible upside, analysts clearly believe Teladoc Health is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.62
Teladoc Health	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

Which has more risk and volatility, HIMS or TDOC?

Hims & Hers Health has a beta of 0.91, meaning that its share price is 9% less volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 0.94, meaning that its share price is 6% less volatile than the S&P 500.

Which has stronger earnings & valuation, HIMS or TDOC?

Hims & Hers Health has higher earnings, but lower revenue than Teladoc Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$872M	3.03	-$23.55M	-$0.11	-112.18
Teladoc Health	$2.60B	0.86	-$220.37M	-$1.34	-9.84

Is HIMS or TDOC more profitable?

Hims & Hers Health has a net margin of -2.70% compared to Teladoc Health's net margin of -8.47%. Hims & Hers Health's return on equity of -7.21% beat Teladoc Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-2.70%	-7.21%	-5.81%
Teladoc Health	-8.47%	-9.22%	-4.89%

Does the MarketBeat Community prefer HIMS or TDOC?

Teladoc Health received 640 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 63.64% of users gave Teladoc Health an outperform vote while only 33.33% of users gave Hims & Hers Health an outperform vote.

Company	Underperform	Outperform
Hims & Hers Health	Outperform Votes 25 33.33%	Underperform Votes 50 66.67%
Teladoc Health	Outperform Votes 665 63.64%	Underperform Votes 380 36.36%

Does the media prefer HIMS or TDOC?

In the previous week, Hims & Hers Health and Hims & Hers Health both had 15 articles in the media. Teladoc Health's average media sentiment score of 0.36 beat Hims & Hers Health's score of 0.25 indicating that Teladoc Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	4 Very Positive mention(s)	3 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Teladoc Health	6 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Do insiders & institutionals believe in HIMS or TDOC?

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 31.6% of Hims & Hers Health shares are owned by insiders. Comparatively, 1.6% of Teladoc Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Teladoc Health beats Hims & Hers Health on 9 of the 17 factors compared between the two stocks.